These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4897300)

  • 21. [Viscosity of blood and sensorineural hearing loss (author's transl)].
    Schulz CE; Richter W; Naujoks J
    Laryngol Rhinol Otol (Stuttg); 1977 Apr; 56(4):328-34. PubMed ID: 140979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Third International Symposium on Audiological Medicine. Visby, Gotland, Sweden, August 18-21, 1985. Pharmacological treatment of inner ear disorders. Audiological aspects of secretory otitis media.
    Scand Audiol Suppl; 1986; 26():1-96. PubMed ID: 3472326
    [No Abstract]   [Full Text] [Related]  

  • 23. [Incidence of disease of the inner ear in toxoplasmosis].
    Luzina AV; Balakina-Kotova NA
    Vestn Otorinolaringol; 1971; 33(1):20-2. PubMed ID: 5552601
    [No Abstract]   [Full Text] [Related]  

  • 24. Lermoyez syndrome; an investigation into its aetiology and into the aetiology of the associated tinnitus.
    BAILIE RW
    J Laryngol Otol; 1956 Feb; 70(2):97-116. PubMed ID: 13307113
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the otoneurological clinical picture in diseases of the labyrinth].
    Kehajov AN
    Monatsschr Ohrenheilkd Laryngorhinol; 1968; 102(7):433-42. PubMed ID: 5303454
    [No Abstract]   [Full Text] [Related]  

  • 26. Relevance of vascular disorders to audiological findings.
    Hopkinson NT; Lindberg RF
    J Speech Hear Disord; 1971 Nov; 36(4):447-50. PubMed ID: 5125796
    [No Abstract]   [Full Text] [Related]  

  • 27. Aescin and troxerutin as a successful combination for the treatment of inner ear perfusion disturbances.
    Siegers CP; Syed Ali S; Tegtmeier M
    Phytomedicine; 2008 Mar; 15(3):160-3. PubMed ID: 18222671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on the inner ear of a deaf domestic mouse mutant with motor disorders in comparison with hereditary labyrinthine hearing disorders in man].
    FISCHER H
    Arch Ohren Nasen Kehlkopfheilkd; 1957; 170(4):411-33. PubMed ID: 13425596
    [No Abstract]   [Full Text] [Related]  

  • 29. [Damage to the inner ear in epidemic parotitis].
    Obradović Z; Zadjvas S
    Med Pregl; 1977; 30(9-10):483-5. PubMed ID: 600213
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case of late congenital syphilitic labyrinthitis-with reference to Hennebert's sign, fluctuating hearing, Herxheimer reaction and therapeutic response of impaired hearing (author's transl)].
    Kamei T; Ishii H; Okawa T; Satake B; Yoda M
    Nihon Jibiinkoka Gakkai Kaiho; 1976 Dec; 79(12):1630-41. PubMed ID: 1035264
    [No Abstract]   [Full Text] [Related]  

  • 31. Bioflavonoid therapy in senxori-neural hearing loss. A double-blind study.
    Creston JE; Gillespie MR; Larson AL
    Trans Am Acad Ophthalmol Otolaryngol; 1966; 70(5):825-40. PubMed ID: 5339343
    [No Abstract]   [Full Text] [Related]  

  • 32. [Loss of hearing, its differential diagnosis and treatment].
    Hussl B
    Wien Klin Wochenschr; 1970 Sep; 82(38):658-61. PubMed ID: 5525315
    [No Abstract]   [Full Text] [Related]  

  • 33. Action of Cavinton on hearing defects of different origin.
    Jasper A
    Ther Hung; 1978; 26(4):181-4. PubMed ID: 751275
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cochleo-vestibular aspects of retinitis pigmentosa].
    Russo C; Zibordi F; De Vita R
    Ann Laringol Otol Rinol Faringol; 1968; 67(2):174-85. PubMed ID: 5757312
    [No Abstract]   [Full Text] [Related]  

  • 35. [Methods of oxygen therapy in hearing disorders of the inner ear].
    Dvoráková V; Pihrt J
    Cesk Otolaryngol; 1975 Aug; 24(4):208-12. PubMed ID: 1164754
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dusodril in the ambulatory care of inner ear disorders].
    Hahn A
    Cesk Otolaryngol; 1989 Sep; 38(5):310-3. PubMed ID: 2582514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of progressive labyrinth hearing disorder].
    KATSNEL'SON EN
    Vestn Otorinolaringol; 1963; 25():102-3. PubMed ID: 13958445
    [No Abstract]   [Full Text] [Related]  

  • 38. [Functional state of the hearing and vestibular analyzers in weavers with professional hearing disorders and their significance in work disability evaluation].
    Solomonov EV
    Vestn Otorinolaringol; 1970; 32(4):21-5. PubMed ID: 5312605
    [No Abstract]   [Full Text] [Related]  

  • 39. Unusual audiological and vestibular problems in the diagnosis of cerebellopontine angle lesions.
    Stroud MH; Thalmann R
    Laryngoscope; 1969 Feb; 79(2):171-200. PubMed ID: 5304525
    [No Abstract]   [Full Text] [Related]  

  • 40. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.
    Matteson EL; Choi HK; Poe DS; Wise C; Lowe VJ; McDonald TJ; Rahman MU
    Arthritis Rheum; 2005 Jun; 53(3):337-42. PubMed ID: 15934127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.